KIMS Hospitals Revenue Up 28.2% to ₹3,930 Cr, PAT Dips 41.7% in FY26

HEALTHCAREBIOTECH
Whalesbook Corporate News Logo
AuthorVihaan Mehta|Published at:
KIMS Hospitals Revenue Up 28.2% to ₹3,930 Cr, PAT Dips 41.7% in FY26

Krishna Institute of Medical Sciences (KIMS) Hospitals reported a 28.2% revenue jump to ₹3,930.8 crore in FY26. However, Profit After Tax fell 41.7% to ₹242 crore due to new hospital expansion costs.

KIMS Hospitals FY26 Results: Revenue Growth Amidst Expansion Costs

Total Revenue: ₹3,930.8 crore (FY26)
Profit After Tax: ₹242.0 crore (FY26)

Reader Takeaway: Strong revenue growth driven by expansion; PAT impacted by new hospital costs.

What just happened

Krishna Institute of Medical Sciences Ltd (KIMS Hospitals) announced its consolidated financial results for the fiscal year 2025-26. The company reported a significant 28.2% increase in total revenue, reaching ₹3,930.8 crore from ₹3,067.0 crore in the previous year. However, Profit After Tax (PAT) saw a substantial decrease of 41.7%, falling to ₹242.0 crore compared to ₹414.8 crore in FY25.

Why this matters

The top-line growth indicates successful expansion and increased patient volumes. The drop in PAT, attributed by management to initial costs of new hospital expansions, signals a short-term profitability hit for long-term investment. This phase of investment is crucial for KIMS's strategy to scale its healthcare network.

The backstory

KIMS Hospitals has been actively expanding its network, reaching 26 hospitals with a bed capacity of over 8,600. The company raised ₹1,500 crore via QIP and ₹600 crore through a preferential allotment to promoters during the year to fund these expansions and manage debt.

What changes now

The company is focused on the operational ramp-up of its new facilities in Palakkad and Chennai. Management aims to improve the EBITDA margin, which stood at 21.1% for FY26, by maturing these new assets and optimizing operating leverage. The Average Revenue Per Occupied Bed (ARPOB) increased by 14% to ₹44,644, reflecting improved specialty services and payor mix.

Risks to watch

Key concerns include the gestation costs of new hospitals which impact PAT in the short term. Input cost inflation, such as manpower and utility costs, could also pressure future margins if not effectively managed.

Peer comparison

While specific peer financial data for FY26 is not provided in the filing, the healthcare sector typically sees similar investment cycles. Companies expanding rapidly often report lower PAT margins temporarily due to upfront costs associated with building and operationalizing new facilities.

Context metrics

KIMS Hospitals operated 26 hospitals with 8,600+ beds (including planned beds) in FY26. Average Revenue Per Occupied Bed (ARPOB) was ₹44,644, a 14% increase year-on-year. The company raised ₹2,100 crore in total funding for its expansion plans.

What to track next

Investors should monitor the timeline for the new hospitals to achieve EBITDA positivity. Progress in reducing the Debt-to-EBITDA ratio below 1.0x and the company's ability to manage operational costs amidst inflation will be key indicators.

Disclaimer: This article is published for informational purposes only. This is not a buy sell recommendation.